drugset
drugset / Trial / NCT04641260

A Study to Assess the Effect of Food With Fezolinetant in Healthy Female Participants

NCT04641260 ↗

Phase 1 Completed 16 enrolled Astellas Pharma Global Development, Inc.
RandomizedCrossoverOpen-labelBasic science

Summary

The purpose of this study is to evaluate the effect of food on the pharmacokinetics of a single oral dose of fezolinetant under fasted and fed conditions in healthy female participants. The study will also evaluate the safety and tolerability of a single oral dose of fezolinetant under fasted and fed conditions in healthy female participants.

Timeline

Start
2020-11-20
Primary completion
2021-02-12
Completion
2021-02-21

Drugs

EvaluationDrugModalityDoseRoute
Subject Fezolinetant Small molecule — Oral

Indications

No indication recorded.